Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 44, 2005, Pages 16019-16024

  Kalinec, Gilda M ^a   Fernandez Zapico, Martin E ^b   Urrutia, Raul ^b   Esteban Cruciani, Nora ^c   Chen, Shanping ^a   Kalinec, Federico ^a,d  

^a HOUSE EAR INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Apoptosis; Extracellular signal regulated kinase 1 2; HEI OC1 cells; L carnitine; Ototoxicity

Indexed keywords

APOPTOSIS INDUCING FACTOR; CARNITINE; GENTAMICIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; PROTEIN HARAKIRI; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUDITORY THRESHOLD; COCHLEA INJURY; CONTROLLED STUDY; DETOXIFICATION; DRUG INDUCED DISEASE; ENERGY METABOLISM; FETUS; GUINEA PIG; HEARING LOSS; NONHUMAN; OTOTOXICITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARNITINE; CELL LINE; COCHLEA; FEMALE; GENTAMICINS; GUINEA PIGS; HEARING LOSS; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROPEPTIDES; PREGNANCY; UP-REGULATION;

ANIMALIA; CAVIA; CAVIA PORCELLUS;

EID: 27644518168     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0508053102     Document Type: Article

References (25)

1. Chambers, H. F. & Sande, M. A. (1996) in Goodman & Gilman's The Pharmacological Basis of Therapeutics, eds. Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W. & Gilman, A. G. (McGraw-Hill, New York), pp. 1103-1121.
2. Romero, R., Espinoza, J., Chaiworapongsa, T. & Kalache, K. (2002) Semin. Neonatal. 7, 259-274.
3. Henley, C. M. & Rybak, L. P. (1995) Brain Res. Brain Res. Rev. 20, 68-90.
4. Priuska, E. M. & Schacht, J. (1995) Biochem. Pharmacol. 50, 1749-1752.
5. Forge, A. & Schacht, J. (2000) Audiol. Neurootol. 5, 3-22.
6. Dehne, N., Rauen, U., de Groot, H. & Lautermann, J. (2002) Hear. Res. 169, 47-55.
7. Fischel-Ghodsian, N. (2003) Ear Hear. 24, 303-313.
8. Shigenaga, M. K., Hagen, T. M. & Ames, B. N. (1994) Proc. Natl. Acad. Sci. USA 91, 10771-10778.
9. Seidman, M., Khan, M., Bain, U., Shirwany, N. & Quirk, W. (2000) Am. J. Otol. 21, 161-167.
10. Willot, J. F., Chisolm, T. H. & Lister, J. J. (2001) Audiol. Neurootol. 6, 231-249.
11. Jongebloed, W. L., Stokroos, I., Van Der Want, J. J. L. & Kalichara, D. (1999) J. Microsc. (Oxford) 193, 158-170.
12. Inohara, N., Ding, L., Chen, S. & Nunez, G. (1997) EMBO J. 16, 1686-1694.
13. Kalinec, G. M., Webster, P., Lim, D. J. & Kalinec, F. (2003) Audiol. Neurootol. 8, 177-189.
14. Cory, S. & Adams, J. M. (2002) Nat. Rev. Cancer 2, 647-656.
15. Borner, C. (2003) Mol. Immunol. 39, 615-647.
16. Imaizumi, K., Benito, A., Kiryu-Seo, S., Gonzalez, V., Inohara, N., Leiberman, A. P., Kiyama, H. & Nunez, G. (2004) J. Neurosci. 24, 3721-3725.
17. Harris, C. A. & Johnson, E. M., Jr. (2001) J. Biol. Chem. 276, 37754-37760.
18. Colucci-D'Amato, L., Perrone-Capano, C. & di Porzio, U. (2003) BioEssays 25, 1085-1095.
19. Pirvola, U., Xing-Qun, L., Virkkala, J., Saarma, M., Murakata, C., Camoratto, A. M., Walton, K. M. & Ylikoski, J. (2000) J. Neurosci. 20, 43-50.
20. Wang, J., Van De Water, T. R., Bonny, C., de Ribaupierre, F., Puel, J. L. & Zine, A. (2003) J. Neurosci. 23, 8596-8607.
21. Matsui, J. I., Gale, J. E. & Warchol, M. E. (2004) J. Neurobiol. 61, 250-266.
22. Wang, X., Martindale, J. L. & Holbrook, N. J. (2000) J. Biol. Chem. 275, 39435-39443.
23. Ylikoski, J., Xing-Qun, L., Virkkala, J. & Pirvola, U. (2002) Hear. Res. 166, 33-43.
24. Sunayama, J., Ando, Y., Itoh, N., Tomiyama, A., Sakurada, K., Sugiyama, A., Kang, D., Tashiro, F., Gotoh, Y., Kuchino, Y. & Kitanaka, C. (2004) Cell Death Differ. 11, 771-781.
25. Pons, R. & De Vivo, D. C. (1995) J. Child Neurol. 10, Suppl. 2, S8-S24.